Genetically modified organisms
A genetically modified organism (GMO) is any living being whose hereditary material has been changed utilizing hereditary designing systems (i.e. hereditarily designed living being). GMOs are the wellspring of pharmaceuticals and hereditarily adjusted sustenances and are likewise generally utilized as a part of logical exploration and to create different merchandise. The term GMO is near the specialized legitimate term, 'living changed creature', characterized in the Cartagena Protocol on Biosafety, which controls universal exchange living GMOs (particularly, "any living life form that has a novel mix of innate material procured through the usage of current biotechnolog").
An all the more particularly characterized sort of GMO is a "Transgenic Organism". This is a creature whose hereditary cosmetics has been modified by the expansion of hereditary material from another, inconsequential living being. This ought not be mistaken for the more broad route in which "GMO" is utilized to arrange hereditarily modified life forms, as normally GMOs are creatures whose hereditary cosmetics has been adjusted without the expansion of hereditary material from an irrelevant life form.
The primary hereditarily adjusted mouse was in 1981, the first plant was created in 1983 and the first hereditarily altered human (changed mitochondrial DNA) was conceived on July 21, 1997.
- Drug Administration
- Investment on personalized medicine
- Molecular Testing
Related Conference of Genetically modified organisms
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Genetically modified organisms Conference Speakers
Recommended Sessions
- Bioprocess Engineering and Biomarkers
- Cancer Genomics
- Chromosomal Abnormalities
- Clinical applications and diagnostics
- Cytogenetics
- Ecogenomics
- Evolution of Novel Genes
- Gene Expression, Regulation And Cloning
- Gene Mapping
- Genetic counseling
- Genetic Disorders Tests
- Genetic engineering techniques
- Genetic Testing Market
- Genetically modified organisms
- Genomic analysis
- Genomic data
- Genomic medicine
- Global DNA and Gene Chip (Microarrays)
- Medical genomics
- Microbial genetics
- Molecular Medicine
- Next generation sequencing
- Novel medical Devices
- Pedigree Methods
- Personalised genomics
- Pharmacogenetics
- Polygenic inheritance
- Prenatal diagnosis
- Reprogenetics
- Teratogenesis and their effects
- Tissue culture techniques
- Tissue Engineering and Regeneration
- Transgenic Research
- Tumor Markers
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)

